Overview

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Status:
NOT_YET_RECRUITING

Trial end date:
2026-05-01

Target enrollment:

Participant gender:

Summary

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension

Phase:

PHASE2

Details

Lead Sponsor:

Bausch & Lomb Incorporated